News Cover
Science

CSIR submits 53 genome sequences of coronavirus to international physique; to share 450 extra by May 15

Amidst considerations that coronavirus have undergone mutation and the brand new pressure possibly extra contagious, India’s premier R&D organisation, CSIR, has submitted as many as 53 genome sequences of the virus to a world genome database, a transfer which will assist in higher understanding of the virus and growing a vaccine.

The Council for Scientific and Industrial Research (CSIR) can also be planning to submit extra 450 genome sequence knowledge of coronavirus by May 15, its Director General Shekhar Mande instructed PTI.

CSIR’s Institute of Genomics and Integrative Biology (IGIB), Delhi, Centre for Cellular and Molecular Biology (CCMB), Hyderabad and Institute of Microbial Technology, Chandigarh are presently sequencing the genomes of the novel coronavirus, he mentioned. Other CSIR institutes are additionally anticipated to hitch the method.

“We have so far submitted 53 genome sequences to the GISAID (Global Initiative on Sharing All Influenza Data). By May 15, we intend to submit additional 450 genome sequences,” Mande mentioned, including all 53 have been sequenced by the scientists on the IGIB.

Genome sequencing is determining the order of DNA nucleotides. It helps in understanding how genes work collectively to direct the expansion, growth and upkeep of an organism.

IGIB Director Anurag Agarwal mentioned in case of coronavirus, sequencing will assist perceive the origins of the virus.

For occasion, if a virus emerges from a selected cluster, sequencing will make it simpler to establish its origin later when it’s present in another a part of the nation or world. Plus, it will likely be useful in making the vaccines and medicines for it, he added.

Earlier this week, a examine by a US-based science laboratory has indicated that there’s a new, highly-potent pressure of coronavirus that has unfold globally and is extra contagious than the virus in early days of the COVID-19 pandemic.

In the Indian context, Mande mentioned the sequences submitted to the GISAID by the CSIR offers with the coronavirus detected in Indians.

Launched in 2008, the GISAID, a public-private partnership between the German authorities and the non-profit group, promotes the fast sharing of information from all influenza viruses and the coronavirus inflicting COVID-19.

This consists of genetic sequence and associated medical and epidemiological knowledge related to human viruses, and geographical in addition to species-specific knowledge linked to avian and different animal viruses.

This permits researchers to know how viruses evolve and unfold throughout epidemics and pandemics.

According to GISAD, greater than 16,000 genome sequences of the coronavirus have been shared with it by totally different institutes on this planet which is able to allow fast progress within the understanding of the brand new COVID-19 illness and within the analysis and growth of medical countermeasures.

“Genomic resources obtained from this sequencing will also allow identification of new targets for diagnosis and drugs for COVID-19,” Sanjeev Khosla, Director, IMTech had mentioned when the method had begun.

Besides, CSIR, the National Institute of Virology, Pune below the Indian Council of Medical Research and Gujarat Biotechnology Research Centre, a state sponsored institute, have additionally submitted genome sequences of coronavirus to the GISAID database. But the variety of sequences submitted by CSIR is excessive.

The CSIR, a physique below the Ministry of Science and Technology, has 38 laboratories coping with a spread of topics.

Globally, greater than 38 lakh individuals have been contaminated by coronavirus, and over 2.6 lakh individuals have died as a result of COVID-19, in line with the World Health Organisation database.

Related posts

Leave a Comment